| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $938K | — | +364.2% |
| Cost of Revenue | $4.5M | — | +75.2% |
| Gross Profit | -$3.5M | — | -50.2% |
| R&D Expense | $2.7M | — | +32.7% |
| SG&A Expense | $3.6M | — | -27.6% |
| Operating Income | -$10.1M | — | -3.4% |
| Net Income | -$10.3M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.9M | +313.4% | +432.8% |
| Accounts Receivable | $1.2M | -57.1% | +588.3% |
| Inventory | $104K | -74.5% | -59.3% |
| Current Assets | $41.5M | +40.6% | +168.1% |
| Total Assets | $101.5M | +20.1% | +37.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.1M | — | -28.6% |
| Investing Cash Flow | -$708K | — | +17.9% |
| Financing Cash Flow | $26.3M | — | +407.4% |
| +11.9% |
| EPS (Basic) | -$0.09 | — | +47.1% |
| EPS (Diluted) | -$0.09 | — | +47.1% |
| $5.3M |
| -61.1% |
| -46.6% |
| Long-term Debt | $2.1M | — | — |
| Total Liabilities | $5.5M | -60.5% | -62.2% |
| Stockholders' Equity | $96.0M | +36.0% | +61.8% |